Reneuron Group (RENE)

 

Latest News

PDMR Interest in Shares and Share Options

RNS Number: 3426T ReNeuron Group plc 11 October 2017 11 October 2017 AIM: RENE ReNeuron Group plc Director/PDMR Interest in Shares and Share Options ReNeuron Group plc (the "Company") (AIM: RENE), a UK-based global leader in the development of cell-based therapeutics, today announces that, on 9 October 2017 , the following grants made on 11 Septe...

Presentation of positive pre-clinical data

RNS Number: 0080T ReNeuron Group plc 09 October 2017 AIM: RENE 9 October 2017 ReNeuron Group plc ReNeuron presents positive pre-clinical data with its ExoPr0 exosome cancer therapy candidate at major scientific conference Data show that ExoPr0 can inhibit proliferation in a diverse panel of cancer cell lines ReNeuron Group plc (the "Company") (AIM:...

Directors' Interest in Shares and Share Options

RNS Number: 4642Q ReNeuron Group plc 12 September 2017 12 September 2017 AIM: RENE ReNeuron Group plc Directors' Interest in Shares and Share Options ReNeuron Group plc (the "Company") (AIM: RENE), a UK-based global leader in the development of cell-based therapeutics, today announces that on 11 September 2017 , the following awards were made u...

Result of AGM

RNS Number: 9753P ReNeuron Group plc 06 September 2017 6 September 2017 AIM: RENE ReNeuron Group plc ("ReNeuron" or the "Company") Result of AGM ReNeuron Group plc (AIM: RENE), a UK-based global leader in the development of cell-based therapeutics, announces that all resolutions put to shareholders at its Annual General Meeting, held earlier to...

All News

DateHeadlineSource
11-10-17PDMR Interest in Shares and Share OptionsRNS
09-10-17Presentation of positive pre-clinical dataRNS
12-09-17Directors' Interest in Shares and Share OptionsRNS
06-09-17Result of AGMRNS
06-09-17AGM Trading UpdateRNS
01-09-17Non-executive Director AppointmentRNS
01-09-17Block Listing Review and TVRRNS
07-08-17Neil Woodford 'very confident' he can deliver 10%-plus yearly returnsMoney Observer
07-08-17Posting of Annual Report and Notice of AGMRNS
04-08-17Second Price Monitoring ExtnRNS
04-08-17Price Monitoring ExtensionRNS
25-07-17Appointment of joint brokerRNS
19-07-17Board changeRNS
29-06-17ReNeuron widens FY pretax lossStockMarketWire
29-06-17Preliminary ResultsRNS
19-06-17ReNeuron says FDA okays cryopreserved hRPC formulationStockMarketWire
19-06-17FDA approves cryopreserved hRPC formulationRNS
08-06-17Notification of Preliminary ResultsRNS
05-06-17ReNeuron gets favourable feedback from US FDAStockMarketWire
05-06-17Positive FDA feedback on proposed Phase III studyRNS
18-05-17ReNeuron presents positive exosome dataStockMarketWire
18-05-17Presents positive exosome data at major conferenceRNS
11-05-17ReNeuron awarded £1.8m grant from Innovate UKStockMarketWire
11-05-17Awarded major UK cell therapy manufacturing grantRNS
05-05-17Presents new exosome data at major conferenceRNS
21-04-17ReNeuron updates on ophthalmology programmesStockMarketWire
21-04-17ReNeuron updates on clinical strategy in stroke disabilityStockMarketWire
21-04-17Update on clinical strategy in stroke disabilityRNS
21-04-17Update on progress in ophthalmology programmesRNS
01-03-17Block Listing Review and Total Voting RightsRNS
15-02-17ReNeuron featured in BBC documentaryRNS
07-02-17Director Deals - ReNeuron Group PLC (RENE)StockMarketWire
07-02-17Director Share PurchaseRNS
01-02-17ReNeuron Group to present at the Shares Spotlight Evening in Edinburgh on 15 February 2017StockMarketWire
14-12-16Director Share PurchaseRNS
05-12-16ReNeuron widens H1 pretax lossStockMarketWire
05-12-16ReNeuron reports positive results in Phase II Stroke TrialStockMarketWire
05-12-16Reports Positive Results in Phase II Stroke TrialRNS
05-12-16Interim ResultsRNS
14-11-16Notification of Interim ResultsRNS

RSS feeds

  • Editorial news feed for LSE:RENE Editorial
  • Regulatory news feed for LSE:RENE Regulatory